Hong Kong SAR
-
China-based Sunkwan Properties Group is looking to Hong Kong as a venue to go public, enlisting ABC International as the sponsor for the IPO. -
Mainland-based Kangji Medical Holdings is seeking approval to list in Hong Kong. It has filed an IPO application with the city’s bourse.
-
Property developer Soho China is in talks with banks for a bridge loan to support its potential take-private deal by private equity firm Blackstone, according to sources close to the situation.
-
In this round-up, Chinese industrial profits recorded the steepest drop in a decade, US president Donald Trump praised China’s understanding of Covid-19 and Hong Kong bourse’s Charles Li said closing the market is not the solution to stem sell-offs.
-
-
An Ke Technology Co, a subsidiary of Chinese conglomerate Ping An Group, is in the market seeking a $300m three year loan.
-
Chinese property developer Radiance Holdings (Group) Co is getting ready to speak to potential investors for its Hong Kong IPO.
-
Chinese pharmaceutical company WuXi AppTec Co is planning to raise primary equity through an issue of H-shares and its Shanghai-listed A-shares.
-
A former joint head of the IPO vetting team in the Hong Kong Stock Exchange's listings department has been charged with bribery and misconduct while in office.
-
China’s Xiaomi Corp is planning to print a Rmb1bn ($141m) private placement Panda bond next week, in what will be the smartphone and appliances maker’s first outing in the onshore bond market.
-
Chinese property management company Redsun Services Group is planning a Hong Kong listing that could raise up to $100m, according to a source familiar with the matter.
-
Chinese biotechnology company InnoCare Pharma’s shares surged over 10% on their Monday debut, following an online opening ceremony for the HK$2.2bn ($288.7m) listing in Hong Kong.
